| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±3.5% | -0.0% | over-priced |
| 05/06/2026 | ±4.4% | -1.2% | over-priced |
| 11/06/2025 | ±4.7% | -2.5% | over-priced |
| 08/07/2025 | ±3.4% | -0.6% | over-priced |
| 05/08/2025 | ±3.3% | +2.1% | over-priced |
| 11/05/2024 | ±1.4% | +1.4% | over-priced |
| 08/08/2024 | ±4.4% | +1.9% | over-priced |
| 05/09/2024 | ±2.5% | +0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.03 | $3.5B | $267M |
| Q1 FY2026 | $1.71 | $2.8B | $230M |
| Q4 FY2025 | $1.49 | $2.9B | $201M |
| Q3 FY2025 | $1.64 | $2.9B | $223M |
Expeditors International of Washington, Inc. (EXPD) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced EXPD's earnings risk. Fundamentals into the print: EPS up 51.5% year-over-year, revenue up 32.1%. QuantLogix's live 5-factor engine currently reads EXPD as a buy at 73/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →